Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

F.D.A. Revokes Approval of Avastin as Breast Cancer Drug
NY Times, NY
Friday, November 18, 2011 - 11:51am
tags:
FDA, Avastin, breast cancer, Roche, Genentech
Affymax Gears Up for its Make-or-Break Moment, As Anemia Drug Faces FDA Scrutiny
Xconomy
Friday, November 18, 2011 - 11:50am
tags:
anemia, FDA, advisory panels, Affymax, peginesatide
Novartis Pays $150M To Settle Pricing Fraud
Pharmalot
Friday, November 18, 2011 - 11:48am
tags:
Novartis, pricing, fraud, settlements, Sandoz, Medicaid
Biotech Takeovers Could Heat Up These Stocks
Seeking Alpha
Friday, November 18, 2011 - 11:47am
tags:
M&A, Acorda, Alnylam, Adolor, Cubist, Chelsea Therapeutics, Catalyst, Human Genome Sciences
Medicis snags Graceway in $455 mln bankruptcy sale
Reuters
Friday, November 18, 2011 - 11:46am
tags:
Medicis, Galderma, Graceway, M&A
Regeneron And Amgen: More Breakthrough Drugs On The Horizon
Seeking Alpha
Friday, November 18, 2011 - 11:45am
tags:
Amgen, Regeneron, AMG145, PCSK9 inhibitor
Par Pharma Takes Over Anchen Pharma
Yahoo/Zacks.com
Friday, November 18, 2011 - 11:43am
tags:
Par Pharmaceutical, M&A, Anchen
Intellipharmaceutics: A Deep Value Opportunity In Generics And Specialty Pharmaceuticals
Seeking Alpha
Friday, November 18, 2011 - 11:42am
tags:
Intellipharmaceutics, generics, Pfizer, AstraZeneca, Novartis, Bristol-Myers Squibb
EU backs Boehringer's Pradaxa despite 256 deaths
Reuters
Friday, November 18, 2011 - 11:41am
tags:
Boehringer Ingelheim, Europe, Pradaxa, bloodthinners
AstraZeneca: Saturn Trial Will Hamper Revenue Growth
Seeking Alpha
Friday, November 18, 2011 - 11:40am
tags:
SATURN, Pfizer, AstraZeneca, Crestor, Lipitor, statins
AstraZeneca Wins EMA Backing for Thyroid Cancer Drug
Motley Fool
Friday, November 18, 2011 - 11:39am
tags:
EMA, AstraZeneca, medullary thyroid cancer, vandetanib
Dendreon: New Trial To Examine Understatement Of Provenge Life-Extension Benefits
Seeking Alpha
Friday, November 18, 2011 - 11:37am
tags:
Dendreon, Provenge, JNJ, prostate cancer
Pfizer: Investors Should Now Focus On Its Pipeline
Seeking Alpha
Friday, November 18, 2011 - 11:06am
tags:
Pfizer
Pfizer near agreement to resolve bribery probe
Fierce Pharma
Thursday, November 17, 2011 - 12:59pm
tags:
Pfizer, bribery, SEC, Wyeth
How Fast Is the Cash at Sequenom?
Motley Fool
Thursday, November 17, 2011 - 12:57pm
tags:
cash, Sequenom
1 Reason Johnson & Johnson's Earnings Aren't So Hot
Motley Fool
Thursday, November 17, 2011 - 12:53pm
tags:
JNJ, earnings
Why Merck's Fair Value Is $46 Per Share
Seeking Alpha
Thursday, November 17, 2011 - 12:52pm
tags:
Merck
F.D.A. Approves Drug for Bone Marrow Disease
NY Times, NY
Thursday, November 17, 2011 - 9:09am
tags:
FDA, myelofibrosis, bone marrow disorder, Jakafi, JAK inhibitors, Incyte
Pfizer Strikes Pharmacy Deals to Hold Lipitor Sales
Bloomberg
Thursday, November 17, 2011 - 9:06am
tags:
statins, pharmacies, Pfizer, Lipitor, Express Scripts
Sanofi's Multaq will no longer be reimbursed in France
Reuters
Thursday, November 17, 2011 - 9:05am
tags:
Sanofi, France, Euripe, Multaq

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.